Jacobs Equity »

Crispr Therapeutics shares owned by Jacobs Equity

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Jacobs Equity from 13F filings

Historical chart of Jacobs Equity investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Jacobs Equity consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Jacobs Equity

Quarter filed Position value Share count Share price at filing
2025-12-31 $634k 12k 52.44

More positions owned by Jacobs Equity

Vanguard Intl Equity Index F Ftse Europe Etf (VGK)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Schwab Strategic Tr Emrg Mkteq Etf (SCHE)
Vanguard Intl Equity Index F Ftse Pacific Etf (VPL)
Select Sector Spdr Tr State Street Tec (XLK)
Schwab Strategic Tr Intl Sceqt Etf (SCHC)
Fidelity Covington Trust Msci Info Tech I (FTEC)
Schwab Strategic Tr Us Mid-cap Etf (SCHM)
Select Sector Spdr Tr State Street Fin (XLF)
Schwab Strategic Tr Us Sml Cap Etf (SCHA)
Vanguard Index Fds Mcap Vl Idxvip (VOE)
Ishares Tr Core Msci Euro (IEUR)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Vanguard Index Fds Mcap Gr Idxvip (VOT)

View all positions for Jacobs Equity

Top funds holding Crispr Therapeutics

ARK Investment Management
BlackRock
Capital Research and Management Company - Division 3
Orbis Allan Gray
State Street Corporation
T. Rowe Price Investment Management
UBS Group
Vanguard Group
Geode Capital Management
Susquehanna International
Sr One Capital Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Citadel Advisors
FMR

View all funds holding Crispr Therapeutics